Company Filing History:
2 out of 5 
1 out of 24 Years Active: 2003-2009
Title: Klaus Unsicker: Innovator in Neuropharmaceuticals
Introduction
Klaus Unsicker is a prominent inventor based in Heidelberg, Germany. He has made significant contributions to the field of neuropharmaceuticals, focusing on treatments for diseases of the nervous system. With a total of 3 patents, Unsicker's work has the potential to impact the lives of many individuals suffering from neurological conditions.
Latest Patents
One of Unsicker's latest patents involves the use of biologically active MP52 or MP121 for the treatment and prevention of diseases of the nervous system. This invention addresses neuropathological situations caused by the aging of the nervous system. The pharmaceutical agent developed under this patent contains MP52 or MP121 as the active substance. Another notable patent relates to a pharmaceutical composition that possesses neurotrophic activity, comprising a biologically active amount of at least two cytokines, including BMP, GDF, TGF-β, or GDNF.
Career Highlights
Throughout his career, Klaus Unsicker has worked with Biopharm Gesellschaft zur Biotechnologischen Entwicklung von Pharmaka and Biopharm Gesellschaft zur Biotechnologischen Entwicklung von Pharmaka mbH. His innovative research has positioned him as a key figure in the development of new therapeutic strategies for neurological disorders.
Collaborations
Unsicker has collaborated with notable professionals in his field, including Jens Pohl and Michael Paulista. These partnerships have further enhanced his research and development efforts in neuropharmaceuticals.
Conclusion
Klaus Unsicker's contributions to the field of neuropharmaceuticals through his patents and collaborations highlight his commitment to advancing treatments for neurological diseases. His work continues to pave the way for innovative solutions in this critical area of medicine.